FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Yelena Mirochnik

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Yelena Mirochnik; Dorina Veliceasa; Irina V Budunova; Kelly Maxwell; Latanya Williams; Alexander Yemelyanov; Olga V Volpert
Androgen receptor drives cellular senescence.
Li Kai; Jun Wang; Marina Ivanovic; Yeon-Tae Chung; William B Laskin; Frank Schulze-Hoepfner; Yelena Mirochnik; Robert L Satcher; Anait S Levenson
Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1).
Arin B Aurora; Aryn B Aurora; Dauren Biyashev; Yelena Mirochnik; Tetiana A Zaichuk; Cristina Sánchez-Martinez; Marie-Ange Renault; Douglas Losordo; Olga V Volpert
NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Yelena Mirochnik (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2012: Yelena Mirochnik; Dorina Veliceasa; Irina V Budunova; Kelly Maxwell; Latanya Williams; Alexander Yemelyanov; Olga V Volpert
Androgen receptor drives cellular senescence.
PloS one 2012;7(3):e31052.
2011: Li Kai; Jun Wang; Marina Ivanovic; Yeon-Tae Chung; William B Laskin; Frank Schulze-Hoepfner; Yelena Mirochnik; Robert L Satcher; Anait S Levenson
Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1).
The Prostate 2011;71(3):268-80.
2010: Arin B Aurora; Aryn B Aurora; Dauren Biyashev; Yelena Mirochnik; Tetiana A Zaichuk; Cristina Sánchez-Martinez; Marie-Ange Renault; Douglas Losordo; Olga V Volpert
NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement.
Blood 2010;116(3):475-84.
2009: Yelena Mirochnik; Arin B. Aurora; Frank T Schulze-Hoepfner; Ahmed Deabes; Victor Shifrin; Richard Beckmann; Charles Polsky; Olga V Volpert
Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(5):1655-63.
2008: Yelena Mirochnik; A Kwiatek; Olga V Volpert
Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.
Current drug targets 2008;9(10):851-62.
2007: Thomas Nelius; Stephanie Filleur; Alexander Yemelyanov; Irina V Budunova; Emelyn H Shroff; Yelena Mirochnik; Arin B. Aurora; Dorina Veliceasa; Wuhan Xiao; Zhou Wang; Olga V Volpert
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.
International journal of cancer. Journal international du cancer 2007;121(5):999-1008.
2007: Yelena Mirochnik; Marvin Rubenstein; Patrick Guinan
Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles.
Journal of drug targeting 2007;15(5):342-50.
2005: Stephanie Filleur; Karl Volz; Thomas Nelius; Yelena Mirochnik; Hanhua Huang; Tetiana Zaichuk; Maria S Aymerich; S Patricia Becerra; Ronald L Yap; Dorina Veliceasa; Emelyn H Shroff; Olga V Volpert
Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer.
Cancer research 2005;65(12):5144-52.
2004: Yelena Mirochnik; Marvin Rubenstein; Patrick Guinan
Two constructed antibody-derived delivery vehicles for targeting oligodeoxynucleotides to prostate tumors expressing prostate specific antigen.
Drug delivery 2004;11(3):161-7.
2003: Marvin Rubenstein; Leonid Slobodskoy; Yelena Mirochnik; Patrick Guinan
Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol.
Medical oncology (Northwood, London, England) 2003;20(1):29-35.
2003: Sandra L Garber; Yelena Mirochnik; Carolyn Brecklin; Leonid Slobodskoy; Jose A L Arruda; George Dunea
Effect of relaxin in two models of renal mass reduction.
American journal of nephrology 2003;23(1):8-12.
2002: Marvin Rubenstein; Leonid Slobodskoy; Yelena Mirochnik; Patrick Guinan
Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines.
Methods and findings in experimental and clinical pharmacology 2002;24(10):649-52.
2001: Marvin Rubenstein; Yelena Mirochnik; Leonid Slobodskoy; Patrick Guinan
Biotinylation of antisense oligonucleotides does not alter lipofectin enhanced cellular uptake in prostate cancer cell lines.
Methods and findings in experimental and clinical pharmacology 2001;23(9):487-90.
2001: Sandra L Garber; Yelena Mirochnik; Carolyn Brecklin; Elaine N Unemori; Ashok K Singh; Leonid Slobodskoy; Beverly H Grove; Jose A L Arruda; George Dunea
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
Kidney international 2001;59(3):876-82.
2001: Marvin Rubenstein; Roberta P Glick; Terry Lichtor; Yelena Mirochnik; P Chou; Patrick Guinan
Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor.
Medical oncology (Northwood, London, England) 2001;18(2):121-30.
2001: Sandra L Garber; Yelena Mirochnik; Jose A L Arruda; George Dunea; Leonid Slobodskoy
Differential effects of enalapril and irbesartan in experimental papillary necrosis.
Kidney & blood pressure research 2001;24(1):39-43.
1999: Marvin Rubenstein; M Shaw; Yelena Mirochnik; Leonid Slobodskoy; Roberta P Glick; Terry Lichtor; P Chou; Patrick Guinan
In vivo establishment of T98G human glioblastoma.
Methods and findings in experimental and clinical pharmacology 1999;21(6):391-3.
1999: Sandra L Garber; Yelena Mirochnik; Jose A L Arruda; George Dunea
Evolution of experimentally induced papillary necrosis to focal segmental glomerulosclerosis and nephrotic proteinuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(6):1033-9.
1998: Marvin Rubenstein; Yelena Mirochnik; P Chou; Patrick Guinan
Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotides.
Methods and findings in experimental and clinical pharmacology 1998;20(10):825-31.
1998: Patrick Guinan; M Shaw; Yelena Mirochnik; Leonid Slobodskoy; V Ray; Marvin Rubenstein
Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model.
Methods and findings in experimental and clinical pharmacology 1998;20(9):739-42.
1998: Sandra L Garber; Yelena Mirochnik; S S Desai; Jose A L Arruda; George Dunea
Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis.
Journal of the American Society of Nephrology : JASN 1998;9(6):1052-9.
1998: M Shaw; S Ratanawong; P Chou; V Ray; Yelena Mirochnik; Leonid Slobodskoy; Marvin Rubenstein; Patrick Guinan
Paclitaxel, bropirimine and linomide: effect on growth inhibition in a murine prostate cancer model by different growth regulatory mechanisms.
Methods and findings in experimental and clinical pharmacology 1998;20(2):111-4.
1998: Ikechukwu L Uzoaru; Marvin Rubenstein; Yelena Mirochnik; Leonid Slobodskoy; M Shaw; Patrick Guinan
An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer.
Journal of surgical oncology 1998;67(1):33-7.
1997: Marvin Rubenstein; Yelena Mirochnik; V Ray; Patrick Guinan
Lack of toxicity associated with the systemic administration of antisense oligonucleotides for treatment of rats bearing LNCaP prostate tumors.
Medical oncology (Northwood, London, England) 1997;14(3-4):131-6.
1997: Marvin Rubenstein; P Chou; Yelena Mirochnik; Patrick Guinan
Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation.
Medical oncology (Northwood, London, England) 1997;14(1):23-9.
1996: G Lievano; Yelena Mirochnik; Marvin Rubenstein; M Shaw; Patrick Guinan
Antitumor effect of CPT-11, a new derivative of camptothecin, against human prostate cancer (PC-3) in vitro and prostate rat tumor (AT-3) in vivo.
Methods and findings in experimental and clinical pharmacology 1996;18(10):659-62.
1996: Marvin Rubenstein; Yelena Mirochnik; P Chou; Patrick Guinan
Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude mice.
Journal of surgical oncology 1996;62(3):194-200.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.